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Abstract
Background: Tree shrew and beijing duck are regarded as animal models resistant to atherosclerosis (AS). This
study was carried out to discover the potential mechanism.
Methods: Blood samples were collected from healthy men and male animals. Plasma lipid profile and activities of
cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP) were measured, compared and
analyzed in human, tree shrew, and Beijing duck.
Results: The results showed that there were species differences on plasma lipid profile and activities of CETP and
PLTP in the three species. Compared with human, tree shrew and beijing duck had higher high density lipoprotein
cholesterol (HDL-C)/total cholesterol (TC) and HDL-C/low density lipoprotein cholesterol (LDL-C) ratios, but lower
CETP and PLTP activities. In the three species, CETP and PLTP activities were negatively related with the ratio of
HDL-C/LDL-C.
Conclusions: The present study suggested that low plasma CETP and PLTP activities may lead to a high HDL-C/
LDL-C ratio and a high resistance to AS finally in tree shrew and beijing duck. Moreover, low PLTP activity may also
make the animals resistant to AS by the relative high vitamin E content of apoB-containing lipoproteins and high
anti-inflammatory and antioxidative properties of HDL particles. A detailed study in the future is recommended.
Background
Cholesteryl ester transfer protein (CETP) and phospholi-
pid transfer protein (PLTP) are two important factors to
transfer lipids in lipoprotein metabolism. CETP transfers
cholesteryl ester from high density lipoprotein (HDL) to
lipoproteins of lower density, partly in exchange for tri-
glycerides. PLTP promotes the transfer of phospholipids
and free cholesterol between lipoproteins [1,2]. It is
reported that CETP and PLTP activities are closely
related to atherosclerosis (AS) [1,2].
Some vertebrate species can be defined as two distinct
groups with low or high atherosclerosis susceptibility
[3]. Cat, dog, mouse and rat belong to the ‘resistant’
group, while chicken, pig, rabbit and man belong to the
‘susceptible’ group. It is showed that plasma lipids trans-
fer activities are significantly different between the two
groups, which exert different effects on the atherogeni-
city of the plasma lipoprotein profile and therefore
make the species resistant or susceptible to athero-
sclerosis [4].
Tree shrew and beijing duck are regarded as animal
m o d e l sr e s i s t a n tt oA S[ 5 , 6 ] .I ti sd o c u m e n t e dt h a t
plasma HDL still remains a relative high level in these
animals and no typical atherosclerotic plaques are found
in the artery wall on a high cholesterol diet. These data
point out a high resistance of tree shrew and beijing
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remains unknown.
In this study, we measured and compared plasma lipid
profile and activities of CETP and PLTP in human, tree
shrew and beijing duck, which might provide some
helpful insights on the anti-atherosclerotic mechanism
in the two species.
Methods
Blood samples
Blood samples from 20-30-year old normolipidemic men
were provided by Central Blood Bank of Peking Union
Medical College Hospital, and blood samples from 6-
month old male tree shrews were provided by Kunming
Institute of Zoology, Chinese Academy of Science. Blood
samples from 4-month old male beijing ducks were gen-
erous gifts of Prof. Suisheng Hou [Institute of Animal
Science (IAS), Chinese Academy of Agricultural Sciences
(CAAS)]. The blood samples were collected into EDTA-
containing glass tubes by veno-puncture. Plasma was
separated by a 5-min centrifugation at 3000 g at 4°C and
was immediately stored at -70°C for further analysis. The
experiments were performed in accordance with the
guidelines of the National Institutes of Health (Bethesda,
MD, USA) and Peking Union Medical College for the
humane treatment of laboratory animals. All efforts were
made to minimize the animals’ suffering.
Plasma lipid assays
Total plasma cholesterol (TC) was measured using
CHOD-PAP method (cholesterol oxidase peroxidase-
phenol 4 amino phenazon), and plasma triglyceride (TG)
was measured using the GPO-PAP method (Glycerol
phosphate oxidase-phenol 4 amino phenazon) (Zhong-
shengbeikong Biotech Co., Ltd, Beijing, China). High
density lipoprotein cholesterol (HDL-C) and low density
lipoprotein cholesterol (LDL-C) were determined by
homogeneous method [synthetic polymer/detergent
HDL-C assay (SPD) method for HDL-C and surfactant
LDL-C assay (SUR) method for LDL-C] (Daiichi Pure
Chemicals Co. LTD., Japan).
Plasma CETP and PLTP activity
Plasma CETP activity was measured using an assay kit
following the manufacturer’s instruction (BioVision,
Mountain View, CA). Briefly, 3 μlo fp l a s m as a m p l e( a s
the source of CETP) was added to the reaction mixture
containing a fluorescent self-quenched neutral lipid as
the donor molecule and an acceptor molecule. A CETP-
mediated transfer of the fluorescent neutral lipid to the
acceptor molecule resulted in an increase in fluores-
cence, which was read in a fluorescence plate reader at
excitation 465 nm and emission 535 nm. CETP activity
was expressed as pico-mole of neutral lipid transferred
per microlitre plasma per hour. Samples were run in tri-
plicate. All CETP analyses were conducted in the same
day to decrease variability. Plasma PLTP activity was
determined using a PLTP activity kit (Bio Vision). The
protocol for the PLTP activity kit was similar to that for
the CETP activity kit.
Statistical analysis
Data were analyzed using SPSS for Windows XP. All
descriptive data collected were expressed as mean ±
standard deviation (SD) and the Student ‘t’ test was
used for analysis. Values of P < 0.05 were regarded as
statistically significant.
Results
Plasma Lipid concentrations
Lipid concentrations were measured in total plasma of
human, tree shrew and beijing duck (Table 1). In the
three species, levels of TC, TG, and HDL-C were high-
est in beijing duck, whereas levels of LDL-C were high-
est in human. Plasma HDL-C/TC and HDL-C/LDL-C
ratios were higher in tree shrew and Beijing duck than
in human (Table 2).
Plasma cholesteryl ester transfer activity
As described in section 2, cholesteryl ester transfer
activity among the three species was evaluated by using
CETP activity assay kit (Table 2). Cholestryl ester trans-
fer rates could be measured in all the studied species.
Plasma CETP activity in human was highest among the
three species, about 59.7 ± 10.5 pmol/μl/h. Plasma
CETP activities in beijing duck and tree shrew were
greatly lower than that in human, respectively 26.1 ± 5.6
and 23.8 ± 4.4 pmol/μl/h. In the three species, CETP
activity was negatively related with the ratio of HDL-C/
LDL-C (r = -0.96063) (Fig. 1).
Plasma phospholipid transfer activity
Plasma PLTP activity was determined by using PLTP
activity assay kit (Table 2). Plasma PLTP activity in human
was about 127.1 ± 18.7 pmol/μl/h, dramatically higher
than that in beijing duck and tree shrew (respectively
80.8 ± 7.8 and 63.2 ± 12.7 pmol/μl/h). In the three species,
PLTP activity was also negatively related with the ratio of
HDL-C/LDL-C (r = -0.99763) (Fig. 2).
Discussion
In our study, compared with human, tree shrew and
beijing duck had high HDL-C/TC and extremely high
HDL-C/LDL-C ratios. In human, the HDL-C level was
lower than the LDL-C level. The HDL-C/LDL-C ratio
was about 0.60. However, in tree shrew and beijing
duck, the HDL-C level was greatly higher than the LDL-
C level. The HDL-C/LDL-C ratio even reached to 2.7 in
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HDL-C is positively and LDL-C is negatively related
with cardiovascular disease [7-9]. When too much LDL-
C circulates in the blood, it can pass from the blood
into the arterial wall where it may be oxidised and
engulfed by macrophages forming foam cells. Thereafter,
a complex interplay of cell necrosis, smooth muscle
recruitment and collagen deposition leads to the devel-
opment of atherosclerotic plaques. However, HDL is
involved in the reverse transport of cholesterol from the
peripheral tissues to the liver, thereby reducing the
uptake of cholesterol by macrophages and providing a
protective effect against atherosclerosis. It also has anti-
inflammatory, antioxidant, or other effects on the arter-
ial wall. Therefore, to reduce the risk of cardiovascular
disease, many strategies have been adopted to decrease
the circulating LDL-C level and increase HDL-C level.
Our study demonstrated that tree shrew and beijing
duck had very high HDL-C level but low LDL-C level,
which might be the reason why the two species were
resistant to AS.
It is reported that mean CETP activity is markedly
lower in the ‘resistant’ g r o u pt h a ni nt h e‘susceptible’
group, but PLTP activity is higher in the ‘resistant’ group
than in the ‘susceptible’ group [4]. In accordance with the
previous findings, in our study, as the species resistant to
AS, tree shrew and beijing duck had dramatically lower
plasma CETP activity than human, the species susceptible
to AS. However, PLTP activity in the two species was
also greatly lower than that in human, which was signifi-
cantly different from the previous report [4]. This may be
because of the species differences. Furthermore, in the
three species, CETP and PLTP activities were negatively
related with the ratio of HDL-C/LDL-C, not as reported
that CETP activity was inversely correlated with HDL-C/
TC ratio [10]. CETP and PLTP are two important factors
to transfer lipids in lipoprotein metabolism. CETP
transfers cholesteryl ester from HDL to lipoproteins of
lower density, partly in exchange for triglycerides. PLTP
promotes the transfer of phospholipids and free choles-
terol between lipoproteins [1,2]. Much research shows
that the deficiency or decrease of CETP activity can lead
to an increase in HDL-C, a decrease in LDL-C, and a
lower incidence of stroke and coronary heart disease
(CHD) [11-13]. However, the increase of CETP activity
decreases the HDL-C level and increases the LDL-C level
and atherosclerosis [14-16]. Although there are some
contrary results too [17,18], most of the studies seem to
suggest that the partial inhibition of CETP appear to pro-
vide a reduction in atherosclerosis and CHD risk.
Numerous in vivo studies show that an increase in
plasma PLTP activity is associated with decreased HDL-C
level, increased hepatic VLDL secretion and increased
atherosclerotic lesion development [19-25]. In addition to
its effect on HDL-C level and VLDL secretion, PLTP can
also influence the atherogenicity of plasma lipoproteins
by decreasing the vitamin E content of apoB-containing
lipoproteins and affecting the anti-inflammatory and anti-
oxidative properties of HDL particles, which results in
increased susceptibility to AS [23,24]. On the contrary,
PLTP deficiency results in markedly decreased athero-
sclerosis by a decrease in the production and levels of
apoB-containing lipoprotein, an increase in their vitamin
E content, and a decrease in their susceptibility to oxida-
tion [23,26]. It is demonstrated that pronounced higher
CETP and PLTP activities can lead to a marked decrease
in HDL-C levels that is due to hypercatabolism [1,27-29]
and an increase in LDL-C levels that is due to an
increase in transfer of CE from HDL to LDL and produc-
tion of apoB-containing lipoprotein [1,26,30,31]. In tree
shrew and beijing duck, low CETP and PLTP activities
might cause a low catabolism of HDL-C and a decrease
in production of apoB-containing lipoprotein, which led
to a relative high plasma level of HDL-C and low level of
Table 2 Activities of plasma CETP and PLTP and ratios of HDL-C/TC and HDL-C/LDL-C in human, beijing duck and tree
shrew
CETP activity PLTP activity
Species n (pmol/μl/h) (pmol/μl/h) HDL-C/TC HDL-C/LDL-C
Human 9 59.7 ± 10.5 127.1 ± 18.7 0.33 ± 0.07 0.60 ± 0.24
Beijing duck 12 26.1 ± 5.6 80.8 ± 7.8 0.50 ± 0.03 1.99 ± 0.37
Tree shrew 9 23.8 ± 4.4 63.2 ± 12.7 0.44 ± 0.05 2.70 ± 1.01
The values are mean ± S.D. of three independent experiments.
Table 1 Plasma lipid concentrations in human, beijing duck and tree shrew
Species n TC(mg/dl) TG(mg/dl) HDL-C(mg/dl) LDL-C(mg/dl)
Human 9 137.75 ± 30.26 63.75 ± 22.59 47.38 ± 9.05 78.25 ± 24.70
Beijing duck 12 166.27 ± 30.38 268.82 ± 54.57 83.45 ± 15.96 42.91 ± 12.20
Tree shrew 9 66.44 ± 9.02 88.22 ± 16.39 29.11 ± 5.16 11.56 ± 3.00
The values are mean ± S.D.
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PLTP activity may also make the animals resistant to AS
by the relative high vitamin E content of apoB-containing
lipoproteins and high anti-inflammatory and antioxidative
properties of HDL particles. Of course, these details need
to be studied further in the future.
Atherosclerotic cardiovascular disease (CVD) is the
leading cause of morbidity and mortality in the indus-
trialized world. The blood concentrations of the lipopro-
tein cholesterol fractions are closely related to the
incidence of CVD. Many attempts have been made to
control the blood lipoprotein cholesterol concentrations
by regulating the activities of those enzymes involved in
the lipoprotein metabolism. Therefore, the completion
of our work may provide some helpful insights on the
clinical treatment of human AS in the future.
Conclusions
T h ep r e s e n ts t u d ys u g g e s t ed that low plasma CETP and
PLTP activities may lead to a high HDL-C/LDL-C ratio
and a high resistance to AS finally in tree shrew and beij-
ing duck. Moreover, low PLTP activity may also make
the animals resistant to AS by the relative high vitamin E
content of apoB-containing lipoproteins and high anti-
inflammatory and antioxidative properties of HDL parti-
cles. A detailed study in the future is recommended.
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